Search

Your search keyword '"Astsaturov, Igor"' showing total 442 results

Search Constraints

Start Over You searched for: Author "Astsaturov, Igor" Remove constraint Author: "Astsaturov, Igor"
442 results on '"Astsaturov, Igor"'

Search Results

151. The role and targeting of Aurora kinases in head and neck cancer

153. Aurora-A kinase (AURKA) in normal and pathological cell growth

154. Fundamental Relatedness of Autoimmunity in Type 1 Diabetes and Multiple Sclerosis

155. Disease-Associated Mimicry Peptides with Opposing Function In Vivo: Mechanistic Implications for Immunotherapy of Autoimmune Diabetes

156. HSP90 Inhibitor–SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors

158. Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR

160. Abstract 4409: STA-12-8666: a first-in-class HSP90 inhibitor drug conjugate (HDC) designed to selectively deliver chemotherapy to tumors

171. Freedom from recurrence after induction cisplatin/5-FU/RT versus carboplatin/paclitaxel/RT in patients with esophageal cancer.

179. Targeting C4-Demethylating Genes in the Cholesterol Pathway Sensitizes Cancer Cells to EGF Receptor Inhibitors via Increased EGF Receptor Degradation

182. A phase I evaluation of vandetanib plus paclitaxel, carboplatin, 5-fluorouracil, and XRT induction therapy followed by surgery for previously untreated locally advanced cancer of the esophagus and GE junction.

185. CRISPR/Cas9 Technique for Identification of Genes Regulating Oxaliplatin Resistance of Pancreatic Cancer Cell Line

186. Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment

187. Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma

188. Chemotherapy and signaling

189. Synthetic Lethal Screen of an EGFR-Centered Network to Improve Targeted Therapies

190. Abstract LB-324: A toll-like receptor 4 agonist enhances the efficacy of trastuzumab therapy and promotes adaptive immunity and long-term protection against a human ErbB-2 (HER2)-transfected syngeneic tumor in a human HER2 transgenic mouse model

197. Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models.

199. Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling

200. Clinical Application of EGFR Inhibitors in Head and Neck Squamous Cell Cancer.

Catalog

Books, media, physical & digital resources